(Q38919674)

English

Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

Philip J Wiffen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Abi Jenkins

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Alison H Thomson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Nicholas M Brown

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yvonne Semple

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Christine Sluman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Alasdair MacGowan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Andrew M Lovering

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

(BSAC Working Party on Therapeutic Drug Monitoring)

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

0 references

publication date

11 July 2016

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2754-2759

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Amikacin once daily: a new dosing regimen based on drug pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

A study of amikacin given once versus twice daily in serious infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Controlled Comparison of Amikacin and Gentamicin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Relationship Between Aminoglycoside-Induced Nephrotoxicity and Auditory Toxicity

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

An evaluation of amikacin nephrotoxicity in the hematology/oncology population

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Individualized pharmacokinetic versus standard dosing of amikacin: a comparison of therapeutic outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Prospective comparative study of efficacy and toxicity of netilmicin and amikacin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Comparison of amikacin and gentamicin in the treatment of urinary tract infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Comparison of Netilmicin and Amikacin in Treatment of Complicated Urinary Tract Infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW250

21 January 2018

Identifiers

10.1093/JAC/DKW250

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27494904%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38919674&oldid=1796209588"